Expanding the Differential During the COVID-19 Pandemic: Fatal West Nile Virus Neuroinvasive Disease
| Autor: | Robert N. Suter, Anh T. Hoang, Stephen J. Titus, Paul A. Figel |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) Health care provider West Nile virus viruses Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 030106 microbiology medicine.disease_cause California West Nile virus in the United States Diagnosis Differential 03 medical and health sciences Neuroinvasive disease Pandemic medicine Humans Pandemics business.industry Public Health Environmental and Occupational Health COVID-19 Texas Virology 030104 developmental biology Family Practice business West Nile Fever |
| Zdroj: | The Journal of the American Board of Family Medicine. 34:661-662 |
| ISSN: | 1558-7118 1557-2625 |
| DOI: | 10.3122/jabfm.2021.03.200630 |
| Popis: | The ever-evolving pandemic of Coronavirus disease 2019 (COVID-19) has the potential to drown out other viruses continuing to infect communities. To highlight this, we present 2 cases of fatal West Nile virus neuroinvasive disease that occurred within 2 weeks of each other. Since the first positive case of West Nile virus in the United States, there have been 2 epidemics in the past 2 decades, most often occurring in regions of North Texas and Southern California, which have been areas of high-incidence for COVID-19. It is important for the health care provider to recognize diagnostic biases and maintain broad differentials for the patient presenting with fever and other symptoms associated with COVID-19. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|